Research
Micronutrients & recovery
Lowering LDL cholesterol with statins reduces major cardiovascular events in Type 2 Diabetes patients, whereas pharmacological interventions to raise HDL cholesterol or lower triglycerides have not shown consistent beneficial effects on cardiovascular risk.
Take statins to lower LDL cholesterol as prescribed. Do not expect drugs that raise HDL or lower triglycerides to protect your heart, as evidence does not support their benefit for cardiovascular outcomes.
StrongSupportsVERY_HIGH confidence
several studies have shown that lowering LDL-C (usually with statins) reduces the risk of major CV events in patients with diabetes... numerous studies of pharmacological interventions to raise HDL-C have not found evidence of a beneficial effect on CV risk.
Why this rating
Supported by multiple studies and meta-analyses cited in the text.
Source
Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus
Daniel Lorber · Diabetes Metabolic Syndrome and Obesity · 2014
DOI 10.2147/dmso.s61438
narrative_reviewCited 170×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Intensive glucose control (targeting HbA1c <6.0-6.5%) in Type 2 Diabetes does not significantly reduce cardiovascular events and may increase mortality, whereas intensive control in Type 1 Diabetes shows a sustained legacy benefit on CV outcomes.Strong
- Lowering blood pressure in Type 2 Diabetes patients reduces the risk of cerebrovascular accidents and congestive heart failure, with ACE inhibitors or ARBs recommended as first-line therapy.Strong
- Intensive lifestyle intervention (caloric restriction + 175 min/week moderate exercise) in overweight/obese T2DM patients reduces cardiovascular risk factors and improves quality of life but does not significantly reduce major cardiovascular events compared to standard diabetes education.Good
Related findings · Micronutrients & recovery
- Trans fats (industrial trans-fatty acids) are unequivocally harmful and should be completely avoided as they raise LDL-C, TGs, and Apo B while lowering HDL-C.Strong
- For menopausal women with osteoporosis, first-line pharmacologic therapies include alendronate, risedronate, zoledronic acid, and denosumab for the prevention of hip, nonvertebral, and vertebral fractures.Strong
- Folic acid fortification of flour prevents neural tube birth defects, and mandatory fortification is more effective than voluntary supplementation alone.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →